297 related articles for article (PubMed ID: 31657827)
41. Provision of contraceptives by Brazilian general gynaecologists: a nationwide online survey.
Canela MRM; Brito LGO; Silva-Filho AL; Bahamondes L; Juliato CRT
Eur J Contracept Reprod Health Care; 2023 Oct; 28(5):251-257. PubMed ID: 37505798
[TBL] [Abstract][Full Text] [Related]
42. Pediatric Resident Perspectives on Long-Acting Reversible Contraception Training: A Cross-Sectional Survey of Accreditation Council for Graduate Medical Education Trainees.
Krass P; Sieke EH; Joshi P; Akers AY; Wood SM
J Adolesc Health; 2023 Jun; 72(6):964-971. PubMed ID: 36907801
[TBL] [Abstract][Full Text] [Related]
43. Advanced Practice Registered Nurses and Long-Acting Reversible Contraception.
Kelly PJ; Cheng AL; Carlson K; Witt J
J Midwifery Womens Health; 2017 Mar; 62(2):190-195. PubMed ID: 28340500
[TBL] [Abstract][Full Text] [Related]
44. Barriers to prescribing of long-acting reversible contraception (LARC) by general practitioner registrars: A cross-sectional questionnaire.
Turner R; Tapley A; Sweeney S; Magin P
Aust N Z J Obstet Gynaecol; 2021 Jun; 61(3):469-473. PubMed ID: 33590480
[TBL] [Abstract][Full Text] [Related]
45. Obstetrics-gynecology resident long-acting reversible contraception training: the role of resident and program characteristics.
Maples JM; Espey E; Evans ML; Breeze JL; Ogburn T; Zite NB
Am J Obstet Gynecol; 2020 Apr; 222(4S):S923.e1-S923.e8. PubMed ID: 31866517
[TBL] [Abstract][Full Text] [Related]
46. Awareness of long-acting reversible contraception among teens and young adults.
Teal SB; Romer SE
J Adolesc Health; 2013 Apr; 52(4 Suppl):S35-9. PubMed ID: 23535055
[TBL] [Abstract][Full Text] [Related]
47. IUD services among primary care practices in New York City.
Jacobson L; Garbers S; Helmy H; Roobol H; Kohn JE; Kavanaugh ML
Contraception; 2016 Mar; 93(3):257-62. PubMed ID: 26569447
[TBL] [Abstract][Full Text] [Related]
48. Peer counselling for the promotion of long-acting, reversible contraception among teens: a randomised, controlled trial.
Wilson SF; Degaiffier N; Ratcliffe SJ; Schreiber CA
Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):380-7. PubMed ID: 27499054
[TBL] [Abstract][Full Text] [Related]
49. Barriers to implementation of long-acting reversible contraception: A systematic review.
Phillips J; Sandhu P
J Am Assoc Nurse Pract; 2018 Apr; 30(4):236-243. PubMed ID: 29757790
[TBL] [Abstract][Full Text] [Related]
50. A Qualitative Study Exploring Contraceptive Practices and Barriers to Long-Acting Reversible Contraceptive Use in a Sample of Adolescents Living in the Southern United States.
Coates C; Gordon CM; Simpson T
J Pediatr Adolesc Gynecol; 2018 Dec; 31(6):605-609. PubMed ID: 30012426
[TBL] [Abstract][Full Text] [Related]
51. Roles of the pharmacist in the use of safe and highly effective long-acting reversible contraception: an opinion of the women's health practice and research network of the American College of Clinical Pharmacy.
Rafie S; McIntosh J; Shealy KM; Borgelt LM; Forinash A; Shrader SP; Koepf ER; McClendon KS; Griffin BL; Horlen C; Karaoui LR; Rowe EL; Lodise NM; Wigle PR
Pharmacotherapy; 2014 Sep; 34(9):991-9. PubMed ID: 24989020
[TBL] [Abstract][Full Text] [Related]
52. Vital signs: trends in use of long-acting reversible contraception among teens aged 15-19 years seeking contraceptive services—United States, 2005-2013.
Romero L; Pazol K; Warner L; Gavin L; Moskosky S; Besera G; Loyola Briceno AC; Jatlaoui T; Barfield W;
MMWR Morb Mortal Wkly Rep; 2015 Apr; 64(13):363-9. PubMed ID: 25856258
[TBL] [Abstract][Full Text] [Related]
53. Factors influencing the provision of long-acting reversible contraception in California.
Biggs MA; Harper CC; Malvin J; Brindis CD
Obstet Gynecol; 2014 Mar; 123(3):593-602. PubMed ID: 24499746
[TBL] [Abstract][Full Text] [Related]
54. Factors Associated with New Uptake of Long-Acting Reversible Contraceptives Since the Affordable Care Act Among Privately Insured Women in Pennsylvania.
Nelson HN; Thayer E; Bailey C; Leuenberger L; Lehman E; Chuang CH
Womens Health Issues; 2019; 29(5):370-375. PubMed ID: 31337530
[TBL] [Abstract][Full Text] [Related]
55. Barriers and Facilitators to Adolescents' Use of Long-Acting Reversible Contraceptives.
Pritt NM; Norris AH; Berlan ED
J Pediatr Adolesc Gynecol; 2017 Feb; 30(1):18-22. PubMed ID: 27477904
[TBL] [Abstract][Full Text] [Related]
56. Teen pregnancy prevention on a LARC: an update on long-acting reversible contraception for the primary care provider.
Dodson NA; Gray SH; Burke PJ
Curr Opin Pediatr; 2012 Aug; 24(4):439-45. PubMed ID: 22732635
[TBL] [Abstract][Full Text] [Related]
57. The effect of mobile video training for healthcare providers on long-acting reversible contraceptive (LARC) use among adolescents and young women.
Xiong W; Li C; Liu X; Gui T; Peng P
J Pediatr Adolesc Gynecol; 2021 Oct; 34(5):686-692. PubMed ID: 34023522
[TBL] [Abstract][Full Text] [Related]
58. Long acting contraception provision by rural primary care physicians.
Lunde B; Smith P; Grewal M; Kumaraswami T; Cowett A; Harwood B
J Womens Health (Larchmt); 2014 Jun; 23(6):519-24. PubMed ID: 24443930
[TBL] [Abstract][Full Text] [Related]
59. Canadian Contraception Consensus (Part 2 of 4).
Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N
J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725
[TBL] [Abstract][Full Text] [Related]
60. Adherence to Swedish national recommendations for long acting reversible contraceptive provision at the time of medical abortion.
Egardt A; Algovik M; Kopp Kallner H
Contraception; 2021 Apr; 103(4):261-264. PubMed ID: 33373614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
